FDA Held Public Hearing on Psychedelic Therapeutics – Wisevoter
Wisevoter staff published their coverage of the FDA hearing on psychedelics on September 29th, and included mention of SSDP’s efforts to influence the direction of future psychedelic policy:
“The FDA hearing utilized both in-person and virtual formats to accommodate diverse stakeholder testimony. Simultaneously, advocates from Students for Sensible Drug Policy conducted an extensive education campaign, targeting over 200 congressional offices to influence national policy.”
